Neuberger Berman Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Sell
80,489
-1,531
-2% -$35.4K ﹤0.01% 1297
2026
Q1
$1.96M Sell
82,020
-19,062
-19% -$466K ﹤0.01% 1190
2025
Q4
$2.29M Sell
101,082
-99
-0.1% -$2.15K ﹤0.01% 1136
2025
Q3
$2.04M Sell
101,181
-594
-0.6% -$9.95K ﹤0.01% 1160
2025
Q2
$1.45M Sell
101,775
-1,085,726
-91% -$12.7M ﹤0.01% 1230
2025
Q1
$12.5M Buy
1,187,501
+54,191
+5% +$613K 0.01% 732
2024
Q4
$13.7M Sell
1,133,310
-196,942
-15% -$2.58M 0.01% 735
2024
Q3
$19.5M Sell
1,330,252
-172,054
-11% -$2.4M 0.02% 661
2024
Q2
$21.7M Buy
1,502,306
+1,413,590
+1,593% +$22.6M 0.02% 617
2024
Q1
$1.44M Sell
88,716
-98,040
-52% -$1.53M ﹤0.01% 1193
2023
Q4
$2.78M Buy
186,756
+96,837
+108% +$1.1M ﹤0.01% 1190
2023
Q3
$1.01M Buy
89,919
+28,270
+46% +$328K ﹤0.01% 1253
2023
Q2
$620K Buy
+61,649
New +$572K ﹤0.01% 1384
2023
Q1
– Sell
-19,584
Closed -$239K – 1825
2022
Q4
$239K Buy
19,584
+7,684
+65% +$95.8K ﹤0.01% 1662
2022
Q3
$148K Buy
+11,900
New +$208K ﹤0.01% 1744
2022
Q2
– Sell
-11,071
Closed -$289K – 1875
2022
Q1
$289K Buy
11,071
+1,432
+15% +$38.1K ﹤0.01% 1715
2021
Q4
$269K Buy
+9,639
New +$300K ﹤0.01% 1759
2021
Q2
– Sell
-7,296
Closed -$215K – 1775
2021
Q1
$215K Hold
7,296
– – ﹤0.01% 1692
2020
Q4
$224K Sell
7,296
-3,974
-35% -$121K ﹤0.01% 1593
2020
Q3
$315K Sell
11,270
-169
-1% -$4.28K ﹤0.01% 1441
2020
Q2
$245K Sell
11,439
-233
-2% -$5.15K ﹤0.01% 1441
2020
Q1
$261K Sell
11,672
-75,880
-87% -$2.08M ﹤0.01% 1372
2019
Q4
$2.58M Sell
87,552
-41,197
-32% -$1.12M ﹤0.01% 976
2019
Q3
$3.42M Sell
128,749
-4,753,965
-97% -$143M ﹤0.01% 907
2019
Q2
$165M Buy
4,882,714
+115,111
+2% +$3.74M 0.2% 135
2019
Q1
$153M Buy
4,767,603
+4,737,403
+15,687% +$146M 0.19% 153
2018
Q4
$952K Sell
30,200
-117,411
-80% -$3.84M ﹤0.01% 1132
2018
Q3
$5.15M Buy
+147,611
New +$5.19M 0.01% 899

Other funds holding ELAN

Neuberger Berman Group's ELAN Position: Q2 2026 in Review

Neuberger Berman Group reduced its Elanco Animal Health (ELAN) stake by 1.9% in Q2 2026, selling an estimated $35.4K and leaving 80,489 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #1297.

Neuberger Berman Group first reported a position in ELAN in Q3 2018 and has held it in 28 quarters since. The position peaked at $165M in Q2 2019. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Neuberger Berman Group held 80,489 shares of Elanco Animal Health worth $1.98M as of Q2 2026.
  • Neuberger Berman Group sold 1,531 Elanco Animal Health shares in Q2 2026, an estimated $35.4K.
  • Elanco Animal Health made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1297 holding.
  • Neuberger Berman Group first reported a position in Elanco Animal Health in Q3 2018 and has held it in 28 quarters since.
  • Neuberger Berman Group's Elanco Animal Health position peaked at $165M in Q2 2019.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.